TY - JOUR
T1 - Viability and functionality of cryopreserved peripheral blood mononuclear cells in pediatric dengue
AU - Perdomo-Celis, Federico
AU - Salgado, Doris M.
AU - Castañeda, Diana M.
AU - Narváez, Carlos F.
N1 - Publisher Copyright:
© Copyright 2016, American Society for Microbiology. All Rights Reserved.
PY - 2016/5
Y1 - 2016/5
N2 - Cryopreserved peripheral blood mononuclear cells (PBMCs) are widely used in studies of dengue. In this disease, elevated frequency of apoptotic PBMCs has been described, and molecules such as soluble tumor necrosis factor (TNF)-related apoptosisinducing ligands (sTRAIL) are involved. This effect of dengue may affect the efficiency of PBMC cryopreservation. Here, we evaluate the viability (trypan blue dye exclusion and amine-reactive dye staining) and functionality (frequency of gamma interferon [IFN-λ-producing T cells after polyclonal stimulation) of fresh and cryopreserved PBMCs from children with dengue (in acute and convalescence phases), children with other febrile illnesses, and healthy children as controls. Plasma sTRAIL levels were also evaluated. The frequencies of nonviable PBMCs detected by the two viability assays were positively correlated (r=0.74; P≤ 0.0001). Cryopreservation particularly affected the PBMCs of children with dengue, who had a higher frequency of nonviable cells than healthy children and children with other febrile illnesses (P≶0.02), and PBMC viability levels were restored in the convalescent phase. In the acute phase, an increased frequency of CD3+ CD8+amine-positive cells was found before cryopreservation (P=0.01). Except for B cells in the acute phase, cryopreservation usually did not affect the relative frequencies of viable PBMC subpopulations. Dengue infection reduced the frequency of IFN-λ-producing CD3+ cells after stimulation compared with healthy controls and convalescent-phase patients (P≤0.003), and plasma sTRAIL correlated with this decreased frequency in dengue (rho=0.56; P≤0.01). Natural dengue infection in children can affect the viability and functionality of cryopreserved PBMCs.
AB - Cryopreserved peripheral blood mononuclear cells (PBMCs) are widely used in studies of dengue. In this disease, elevated frequency of apoptotic PBMCs has been described, and molecules such as soluble tumor necrosis factor (TNF)-related apoptosisinducing ligands (sTRAIL) are involved. This effect of dengue may affect the efficiency of PBMC cryopreservation. Here, we evaluate the viability (trypan blue dye exclusion and amine-reactive dye staining) and functionality (frequency of gamma interferon [IFN-λ-producing T cells after polyclonal stimulation) of fresh and cryopreserved PBMCs from children with dengue (in acute and convalescence phases), children with other febrile illnesses, and healthy children as controls. Plasma sTRAIL levels were also evaluated. The frequencies of nonviable PBMCs detected by the two viability assays were positively correlated (r=0.74; P≤ 0.0001). Cryopreservation particularly affected the PBMCs of children with dengue, who had a higher frequency of nonviable cells than healthy children and children with other febrile illnesses (P≶0.02), and PBMC viability levels were restored in the convalescent phase. In the acute phase, an increased frequency of CD3+ CD8+amine-positive cells was found before cryopreservation (P=0.01). Except for B cells in the acute phase, cryopreservation usually did not affect the relative frequencies of viable PBMC subpopulations. Dengue infection reduced the frequency of IFN-λ-producing CD3+ cells after stimulation compared with healthy controls and convalescent-phase patients (P≤0.003), and plasma sTRAIL correlated with this decreased frequency in dengue (rho=0.56; P≤0.01). Natural dengue infection in children can affect the viability and functionality of cryopreserved PBMCs.
UR - http://www.scopus.com/inward/record.url?scp=84969706589&partnerID=8YFLogxK
U2 - 10.1128/CVI.00038-16
DO - 10.1128/CVI.00038-16
M3 - Article
C2 - 26961858
AN - SCOPUS:84969706589
SN - 1556-6811
VL - 23
SP - 417
EP - 426
JO - Clinical and Vaccine Immunology
JF - Clinical and Vaccine Immunology
IS - 5
ER -